Finance News - Fda

All U.S. UK Canada Australia Europe India Global Crypto

No results found

Type at least 2 characters to search

Loading tags...

No matching tags found

Filter by:

Any time Past hour Past 24 hours Past week Past month Past year

All Sources ABC News Business BBC Business Business Insider Markets City A.M. CNBC Business CoinDesk Coinpedia Cointelegraph Crypto News CryptoSlate Decrypt Economic Times Markets Euronews Business Financial Post Top Stories Financial Times Globe and Mail Investing Investing.com Global Mkts Investopedia Kiplinger MarketWatch MarketPulse MarketWatch Top Stories Quartz Sky News Money Sydney Morning Herald Biz TechCrunch Fintech The Block The Guardian – Business WSJ Markets News

All Access Types Free Limited Free Subscription Required

Category Fda

The Guardian – Business • 08/20/2025 • Free

Walmart recalls potentially radioactive shrimp sold in 13 US states

The recall of frozen shrimp due to radioactive contamination may lead to significant financial losses for the retailer, impacting sales, supply chain...

Read Full Article →

Quartz • 08/18/2025 • Free

Half-off Ozempic deal sends Novo Nordisk stock surging

The recent approval for Novo Nordisk’s Wegovy drug in liver treatment, combined with a major discount on Ozempic, has led to a notable increase in the...

Read Full Article →

Quartz • 08/11/2025 • Free

FDA biologics chief back 12 days after resigning, creating pressure on biotech stocks

The unexpected return of the FDA biologics leader shortly after stepping down has introduced uncertainty, leading to a decline in the valuation of var...

Read Full Article →

Investopedia • 07/29/2025 • Free

Sarepta Therapeutics Stock Surges as FDA Allows Elevidys Sales to Resume

The approval to restart Elevidys sales has notably impacted Sarepta Therapeutics' market value, reflecting investor confidence and a positive shift in...

Read Full Article →

Business Insider Markets • 07/22/2025 • Free

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action - Hagens Berman

The FDA’s suspension of a key clinical study for Rocket Pharmaceuticals has led to a substantial decline in the company’s market value and the initiat...

Read Full Article →

MarketWatch Top Stories • 07/22/2025 • Free

Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

The decision to stop shipments of the gene therapy in response to regulatory demands has led to a decline in shareholder confidence, impacting the com...

Read Full Article →

Investopedia • 07/21/2025 • Free

Sarepta Stock Keeps Sliding as Company Rejects FDA Call to Withdraw Drug

The company’s shares declined further after it declined the regulatory agency’s request to remove its medication from the market, raising concerns abo...

Read Full Article →

MarketWatch Top Stories • 07/21/2025 • Free

Sarepta stock extends decline as company declines FDA call to withdraw drug

Sarepta Therapeutics' shares continued to fall following the company's decision to reject the FDA’s request to remove a medication linked to multiple...

Read Full Article →

Business Insider Markets • 07/19/2025 • Free

Sarepta drops another 5% to $13.37 after downgrades, FDA probe

The company’s shares declined significantly following reduced analyst ratings and an ongoing investigation by regulatory authorities, impacting invest...

Read Full Article →

Quartz • 07/16/2025 • Free

Knockoff weight loss drugs were supposed to be 'gone and illegal.' Now they're bigger than ever

Despite regulatory efforts to eliminate counterfeit weight loss medications, compounding pharmacies have found a way to continue production, resulting...

Read Full Article →

CNBC Business • 07/11/2025 • Free

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

The FDA’s new approach to factoring in drug affordability during voucher issuance may influence the overall cost dynamics and market access for medica...

Read Full Article →

Quartz • 07/09/2025 • Free

Biotech startups are facing a new threat

Recent reductions in government support and regulatory challenges have caused investors to become more cautious, potentially limiting financial resour...

Read Full Article →

CNBC Business • 06/18/2025 • Free

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The approval of Gilead’s biannual HIV prevention injection presents a significant development in treatment options, though its impact may be influence...

Read Full Article →

Business Insider Markets • 06/18/2025 • Free

Hairmax Partners with Truemed to Accept FSA/HSA Payments on FDA-Cleared Laser Hair Growth Devices

The collaboration enables customers to utilize pre-tax health savings accounts for purchasing advanced FDA-approved hair restoration products, potenti...

Read Full Article →

Investopedia • 06/13/2025 • Free

Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda

The recent FDA authorization to broaden the application of Merck's leading medication could potentially increase the company's revenue by accessing ne...

Read Full Article →

CNBC Business • 06/09/2025 • Free

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales...

Read Full Article →

Business Insider Markets • 06/03/2025 • Free

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

The newly granted patent for Biofrontera’s updated topical treatment extends intellectual property rights until 2043, potentially securing long-term r...

Read Full Article →

Investopedia • 06/02/2025 • Free

Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine

The approval of Moderna's latest COVID-19 vaccine by the FDA has positively influenced investor confidence, leading to a notable rise in the company's...

Read Full Article →

Business Insider Markets • 05/31/2025 • Free

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

The FDA’s authorization of Moderna’s latest vaccine is expected to enhance the company’s market portfolio, potentially driving increased revenue strea...

Read Full Article →

Business Insider Markets • 05/28/2025 • Free

Levi & Korsinsky Launches Fraud Investigation on Behalf of Savara Inc. (SVRA) Shareholders

The initiation of a probe into potential legal breaches related to Savara Inc.'s recent regulatory setback may impact investor confidence and influenc...

Read Full Article →

CNBC Business • 05/20/2025 • Free

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

The FDA’s conditional approval of Novavax’s Covid-19 vaccine, despite limitations, may influence the company’s market performance and future revenue p...

Read Full Article →

Investopedia • 05/20/2025 • Free

Moderna Stock Jumps on New FDA COVID-19 Booster Guidelines

The announcement of updated FDA recommendations for COVID-19 boosters led to a notable increase in Moderna’s share value, reflecting investor optimism...

Read Full Article →

Business Insider Markets • 05/06/2025 • Free

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

The recent court decision enables Avadel Pharmaceuticals to continue advancing clinical studies and potentially secure regulatory clearance for its tr...

Read Full Article →

Cointelegraph • 04/30/2025 • Free

EU digital product passports won’t solve food fraud, but blockchain can

The implementation of self-sovereign identity technology is proposed as a more effective solution than the EU's digital product passports to combat fo...

Read Full Article →

Page 2 of 2

1 2

Price Alerts

Sign in to create alerts

Finance News - Fda

Walmart recalls potentially radioactive shrimp sold in 13 US states

Half-off Ozempic deal sends Novo Nordisk stock surging

FDA biologics chief back 12 days after resigning, creating pressure on biotech stocks

Sarepta Therapeutics Stock Surges as FDA Allows Elevidys Sales to Resume

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action - Hagens Berman

Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

Sarepta Stock Keeps Sliding as Company Rejects FDA Call to Withdraw Drug

Sarepta stock extends decline as company declines FDA call to withdraw drug

Sarepta drops another 5% to $13.37 after downgrades, FDA probe

Knockoff weight loss drugs were supposed to be 'gone and illegal.' Now they're bigger than ever

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

Biotech startups are facing a new threat

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

Hairmax Partners with Truemed to Accept FSA/HSA Payments on FDA-Cleared Laser Hair Growth Devices

Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

Levi & Korsinsky Launches Fraud Investigation on Behalf of Savara Inc. (SVRA) Shareholders

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Moderna Stock Jumps on New FDA COVID-19 Booster Guidelines

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

EU digital product passports won’t solve food fraud, but blockchain can

Featured Sources

What is your interest today?

Sign in to continue

Weekly limit reached

Export limit reached

Historical lookups used

Extended Charts - Pro Feature

Cloud Export - Pro Feature

Finance News - Fda

Featured Sources

What is your interest today?

Format Settings

Language

Localized Format

Decimal Format